Fundraising FoxImago
acquired by Merck16 known investors
Find your way into Imago
Sign up to find every way you can get introduced to Imago
- Your email: who you already know at Imago, and who your contacts know
- 2nd- and 3rd-degree connections: people you know who worked, studied or invested with the Imago team
- Your LinkedIn: the connections who can make the intro for you
We rank every route by how warm it is, so you raise on warm intros instead of cold emails.
A pharmaceutical company that develops medicines and vaccines, with research pipelines and clinical trials aimed at new treatments. It has operated for over 130 years and serves patients and healthcare needs globally.
Investors · 16
How we know: Frazier Life Sciences's portfolio page · Not right? Tell us
How we know: Highlight Capital's portfolio page · medcitynews.com · Not right? Tell us
How we know: MRL Ventures Fund's portfolio page · medcitynews.com · Not right? Tell us
How we know: Xeraya Capital's portfolio page · medcitynews.com · Not right? Tell us
How we know: funding news · medcitynews.com · Not right? Tell us
How we know: medcitynews.com · Not right? Tell us
How we know: medcitynews.com · Not right? Tell us
How we know: funding news · Not right? Tell us
How we know: funding news · medcitynews.com · Not right? Tell us
How we know: medcitynews.com · Not right? Tell us
Also in the syndicate · 4
Funding
SEC filings, press & company announcements- Undisclosed amountSeries CNov 2020
Farallon Capital Management (lead), Amgen Ventures, Blackrock Advisors, Blackstone Life Sciences, Frazier Healthcare Partners, Greenspring Associates, HighLight Capital, Irving Investors, Kindgon Capital Management, MRL Ventures Fund, Pharmaron Investments, Surveyor Capital, T. Rowe Price Associates, Xeraya Capital
Source ↗
Source: company announcements and press reports — follow each round's link for the claim.
Frequently asked questions
- What does Imago do?
- A pharmaceutical company that develops medicines and vaccines, with research pipelines and clinical trials aimed at new treatments. It has operated for over 130 years and serves patients and healthcare needs globally.
- Who are Imago's investors?
- Imago's investors include Frazier Life Sciences, Highlight Capital, MRL Ventures Fund, Xeraya Capital, Amgen Ventures, BlackRock, Blackstone Life Sciences, Clarus Ventures and 4 more.
- Who acquired Imago?
- Imago was acquired by Merck.